Ignite Creation Date:
2025-12-24 @ 3:43 PM
Ignite Modification Date:
2026-01-16 @ 8:07 AM
Study NCT ID:
NCT00716092
Status:
COMPLETED
Last Update Posted:
2014-06-27
First Post:
2008-07-15
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
The Effect of Linagliptin (BI 1356) on 24h-glucose Control and Various Biomarkers in Type 2 Diabetic Patients
Sponsor:
Boehringer Ingelheim
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Diabetes Mellitus, Type 2 | View |
Keywords: